BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 21150387)

  • 1. A preliminary result of treatment of neuromyelitis optica with autologous peripheral hematopoietic stem cell transplantation.
    Peng F; Qiu W; Li J; Hu X; Huang R; Lin D; Bao J; Jiang Y; Bian L
    Neurologist; 2010 Nov; 16(6):375-8. PubMed ID: 21150387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous hematopoietic stem cell transplantation in neuromyelitis optica: a registry study of the EBMT Autoimmune Diseases Working Party.
    Greco R; Bondanza A; Oliveira MC; Badoglio M; Burman J; Piehl F; Hagglund H; Krasulova E; Simões BP; Carlson K; Pohlreich D; Labopin M; Saccardi R; Comi G; Mancardi GL; Bacigalupo A; Ciceri F; Farge D
    Mult Scler; 2015 Feb; 21(2):189-97. PubMed ID: 25078274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of autologous hematopoietic stem cell transplantation to prevent relapse of neuromyelitis optica.
    Matiello M; Pittock SJ; Porrata L; Weinshenker BG
    Arch Neurol; 2011 Jul; 68(7):953-5. PubMed ID: 21403004
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical outcome of autologous peripheral blood stem cell transplantation in opticospinal and conventional forms of secondary progressive multiple sclerosis in a Chinese population.
    Xu J; Ji BX; Su L; Dong HQ; Sun WL; Wan SG; Liu YO; Zhang P; Liu CY
    Ann Hematol; 2011 Mar; 90(3):343-8. PubMed ID: 20872003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study.
    Burt RK; Loh Y; Cohen B; Stefoski D; Balabanov R; Katsamakis G; Oyama Y; Russell EJ; Stern J; Muraro P; Rose J; Testori A; Bucha J; Jovanovic B; Milanetti F; Storek J; Voltarelli JC; Burns WH
    Lancet Neurol; 2009 Mar; 8(3):244-53. PubMed ID: 19186105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study.
    Pittock SJ; Lennon VA; McKeon A; Mandrekar J; Weinshenker BG; Lucchinetti CF; O'Toole O; Wingerchuk DM
    Lancet Neurol; 2013 Jun; 12(6):554-62. PubMed ID: 23623397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preliminary assessment of immune reconstitution after autologous peripheral hematopoietic stem cell transplantation (AHSCT)].
    Huang HQ; Cai QC; Shi YX; Lin XB; Wei J; Guo Y; Pan ZH
    Ai Zheng; 2006 Aug; 25(8):1023-8. PubMed ID: 16965687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of autologous hematopoietic stem cell transplantation in severe cases of neuromyelitis optica spectrum disorder.
    Naser Moghadasi A
    J Clin Neurosci; 2023 Sep; 115():166. PubMed ID: 37258338
    [No Abstract]   [Full Text] [Related]  

  • 9. Human umbilical cord mesenchymal stem cell therapy on neuromyelitis optica.
    Lu Z; Ye D; Qian L; Zhu L; Wang C; Guan D; Zhang X; Xu Y
    Curr Neurovasc Res; 2012 Nov; 9(4):250-5. PubMed ID: 22873728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poor lymphocyte recovery following CD34-selected autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma.
    Diviné M; Boutolleau D; Delfau-Larue MH; Beaujean F; Jouault H; Reyes F; Kuentz M; Bensussan A; Farcet JP; Boumsell L
    Br J Haematol; 1999 May; 105(2):349-60. PubMed ID: 10233403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune reconstitution and production of intracellular cytokines in T lymphocyte populations following autologous peripheral blood stem cell transplantation.
    Schlenke P; Sheikhzadeh S; Weber K; Wagner T; Kirchner H
    Bone Marrow Transplant; 2001 Aug; 28(3):251-7. PubMed ID: 11535992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic hematopoietic stem cell transplantation for neuromyelitis optica.
    Greco R; Bondanza A; Vago L; Moiola L; Rossi P; Furlan R; Martino G; Radaelli M; Martinelli V; Carbone MR; Lupo Stanghellini MT; Assanelli A; Bernardi M; Corti C; Peccatori J; Bonini C; Vezzulli P; Falini A; Ciceri F; Comi G
    Ann Neurol; 2014 Mar; 75(3):447-53. PubMed ID: 24318127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autologous Hematopoietic Stem Cell Transplantation for the Treatment of Neuromyelitis Optica in Singapore.
    Hoay KY; Ratnagopal P
    Acta Neurol Taiwan; 2018 Mar; 27(1):26-32. PubMed ID: 30315559
    [No Abstract]   [Full Text] [Related]  

  • 14. Longitudinal assessment of hematopoietic abnormalities after autologous hematopoietic cell transplantation for lymphoma.
    Bhatia R; Van Heijzen K; Palmer A; Komiya A; Slovak ML; Chang KL; Fung H; Krishnan A; Molina A; Nademanee A; O'Donnell M; Popplewell L; Rodriguez R; Forman SJ; Bhatia S
    J Clin Oncol; 2005 Sep; 23(27):6699-711. PubMed ID: 16170178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous hematopoietic stem cell transplantation for progressive multiple sclerosis: report of efficacy and safety at three yr of follow up in 21 patients.
    Ni XS; Ouyang J; Zhu WH; Wang C; Chen B
    Clin Transplant; 2006; 20(4):485-9. PubMed ID: 16842526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of mitoxantrone for the treatment of recurrent neuromyelitis optica (Devic disease).
    Weinstock-Guttman B; Ramanathan M; Lincoff N; Napoli SQ; Sharma J; Feichter J; Bakshi R
    Arch Neurol; 2006 Jul; 63(7):957-63. PubMed ID: 16831964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome of autologous stem cell transplantation in light chain deposition disease.
    Lorenz EC; Gertz MA; Fervenza FC; Dispenzieri A; Lacy MQ; Hayman SR; Gastineau DA; Leung N
    Nephrol Dial Transplant; 2008 Jun; 23(6):2052-7. PubMed ID: 18178602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous non-myeloablative haematopoietic stem cell transplantation for refractory systemic vasculitis.
    Statkute L; Oyama Y; Barr WG; Sufit R; Ho S; Verda L; Loh Y; Yaung K; Quigley K; Burt RK
    Ann Rheum Dis; 2008 Jul; 67(7):991-7. PubMed ID: 17947303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A preliminary result of treatment of progressive multiple sclerosis with autologous peripheral blood stem cell transplantation in China].
    Ouyang J; Ni X; Chen B
    Zhonghua Nei Ke Za Zhi; 2001 Aug; 40(8):550-2. PubMed ID: 11718058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune reconstitution after autologous hematopoietic stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications.
    Steingrimsdottir H; Gruber A; Björkholm M; Svensson A; Hansson M
    Haematologica; 2000 Aug; 85(8):832-8. PubMed ID: 10942930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.